Editorial: is age just a number when it comes to treatment of inflammatory bowel disease? Authors' reply

Aliment Pharmacol Ther. 2020 Nov;52(10):1617-1618. doi: 10.1111/apt.16106.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Antibodies, Monoclonal, Humanized
  • Cohort Studies
  • Comorbidity
  • Humans
  • Inflammatory Bowel Diseases* / drug therapy
  • Prospective Studies
  • Ustekinumab*

Substances

  • Antibodies, Monoclonal, Humanized
  • vedolizumab
  • Ustekinumab